Leerink Partners raises UnitedHealth target to $462

0 min read | Published on 17 Jun 2026, 09:19 PM |Updated on 17 Jun 2026, 09:19 PM

Reviewed by

Radhika SScanX News Team

Key Highlights

Leerink Partners analyst Whit Mayo maintained an Outperform rating on UnitedHealth Group and raised the price target to $462 from $400.

*this image is generated using AI for illustrative purposes only.

Leerink Partners analyst Whit Mayo has maintained an Outperform rating on UnitedHealth Group while raising the stock's price target to $462 from $400. The adjustment reflects a revised valuation outlook for the healthcare giant.

Rating and Price Target

The research note reinforces a positive stance on UnitedHealth Group's shares. Below are the updated details:

Metric	Value
Rating	Outperform
Previous Price Target	$400
New Price Target	$462

The new target represents a significant increase from the prior level.

What specific factors drove Leerink Partners to revise their valuation outlook for UnitedHealth Group?

How might this price target increase influence other analysts' ratings on UnitedHealth Group?

What are the potential risks that could prevent UnitedHealth Group from reaching the new $462 price target?

UnitedHealth Group to announce Q2FY26 results on July 16

0 min read | Published on 12 Jun 2026, 01:47 AM |Updated on 12 Jun 2026, 01:47 AM

Reviewed by

Naman SScanX News Team

Add as a preferred
source on Google

Key Highlights

UnitedHealth Group will release its second quarter 2026 financial results on Thursday, July 16, 2026, before the market opens. The company will host a teleconference at 8:00 a.m. ET to discuss the results with analysts and investors. A webcast replay will be available on its website until July 30, 2026.

*this image is generated using AI for illustrative purposes only.

UnitedHealth Group will release its second quarter 2026 financial results on Thursday, July 16, 2026, before the market opens. The company will host a teleconference at 8:00 a.m. ET to discuss the performance with analysts and investors. This announcement sets the schedule for stakeholders to assess the company's operational progress during the period.

Conference Details

The earnings call will be accessible via webcast on the Investor Relations page of UnitedHealth Group's website. Investors and interested parties can listen to the live discussion or access the replay, which will be available through July 30, 2026.

About UnitedHealth Group

UnitedHealth Group operates as a healthcare and well-being company. It functions through two primary businesses: Optum and UnitedHealthcare. Optum delivers care supported by technology and data, while UnitedHealthcare provides a spectrum of health benefits designed to offer affordable coverage and simplify the healthcare experience.

How might UnitedHealth Group's Q2 2026 results reflect the impact of any recent regulatory changes in the healthcare sector?

What strategies could UnitedHealth Group employ to address potential challenges in maintaining affordable coverage amid rising healthcare costs?

How might the integration of technology and data within Optum influence the company's operational efficiency and profitability in the coming quarters?